HIV-1 CA mutations selected during passage in rhTRIM5α-expressing cells decrease sensitivity to rhTRIM5α. by Steven J. Soll (270043)

POS treatment decreases ROS level and upregulates mitochondrial biogenesis in ARPE-19 cells through PGC-1α. by Murilo F. Roggia (755997)

“…<p><b>(A)</b> POS treatment upregulated mRNA levels of anti-oxidant enzymes including GPx1, GPx4, SOD1 and catalase. Mean ± SEM, n = 6 per group, two-tailed Student’s <i>t</i>-test, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001; ns, not significant. …”

Inhibition of ATR activation significantly decreases B19V-induced G2 arrest in infected CD36⁺ EPCs. by Peng Xu (17962)

Gal-9 treatment decreases levels of MMP-9, MMP-2 and TIMP-1 but not neutrophil chemoattractants in BALF. by Yuko Horio (4243405)

Astrocytes express a ligand for NKp44 and increasing concentrations of HIV 3S peptide decreases its expression. by Kelly E. Bowen (4857370)

Spectral sensitivity (i.e., responses to monochromatic light) of European sea bass. by Richard W. Brill (2337940)

Targeted point mutation (F639A) in the GluN1 subunit decreases ethanol sensitivity of NMDA receptors. by Carolina R. den Hartog (484817)

Knockdown of HIF-1α decreases osteolytic lesions and improves survival of mice <i>in vivo</i>. by Lauren K. Dunn (260121)

Loss of <i>Ubr5</i> function resulted in decreased expression of <i>Ptch1</i> and <i>Gli1</i> at E13.5. by Elaine Kinsella (2833466)

<i>Igf1r</i> deficiency decreases airway inflammation and remodeling after HDM exposure. by Sergio Piñeiro-Hermida (837279)

The M650K mutation decreases the firing rate of DRG neurons. by Andreas M. Kist (3106548)

Reduction of SIRT1 during DNA damage decreases the number of silent clones that have methylation. by Heather M. O'Hagan (271283)

“…(B) A dot plot of the mean number of CpGs methylated per HSVTK silenced clone from either un-siRNA treated cells (untreated) (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000155#pgen-1000155-g005" target="_blank">Figure 5D & E</a>), non-target siRNA treated cells (NT), or SIRT1 siRNA treated cells (SIRT1). …”

Image_1_Chemical Similarity of Co-occurring Trees Decreases With Precipitation and Temperature in North American Forests.jpg by Brian E. Sedio (10875330)

“…Variation in metabolite richness among communities was positively correlated with species richness, but variation in mean chemical similarity was not. Our results are consistent with the hypothesis that plant metabolomes play a more important role in community assembly in wetter and warmer climates, even at temperate latitudes, and suggest that metabolomic traits can provide unique insight to studies of trait-based community assembly.…”

LRRK2-KO neurites show increased motility and those from LRRK2-WT^OE and LRRK2-G2019S^OE show decreased motility on PLL. by Bryan Sepulveda (408810)

Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

“…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

Decreased <i>dpak</i> or <i>gluriia</i> gene dosages suppress <i>henji</i> phenotypes. by Manyu Wang (3219621)

IL-7 decreases apoptosis of HIV-1-infected CD4⁺ T cells. by Andrea Introini (284643)

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Loss of virulence in the SIN kinase mutants is characterized by decreased fungal burden and host response to infection. by Ana Camila Oliveira Souza (8180958)

“…***p < 0.0001; **p = 0.0014. <b>E)</b> Inflammasome dependence of IL-1β release was established by co-culturing PMA-activated WT (THP1-null), <i>Nlrp3</i>^−/− (THP1-KO-NLRP3), and <i>Asc</i>^−/− (THP1-KO-ASC) THP-1 cells with CEA10 conidia (MOI 10:1) as indicated for (D). …”